SEC Form 4 · accession 0001562180-17-001660
vTv Therapeutics Inc. · VTVT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John A Fry
Director
Period of report
May 1, 2017
Accepted (ET)
May 3, 2017 · 11:33 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001641489
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director stock option (right to buy)F1 | $5.31 | May 1, 2017 | A | 15,000 | A | — | May 1, 2027 | Class A common stock | 15,000 | 32,500 | D |
Explanation of responses
- F1The option vests in monthly equal installments over the three year period beginning on May 1, 2017.